Investment Director, Wu Capital
Hannah H. Chang, M.D., Ph.D. is an Investment Director at Wu Capital USA, focused on US-based biotech venture capital investments. Wu Capital is the single family office of Wu Yajun, Founder and Chairwoman of Longfor Properties. Dr. Chang was previously an investment professional at 5AM Ventures where she served as Board Observer for Ambrx, Biodesy, Cleave, Crinetics and IDEAYA Biosciences. Earlier in her career Dr. Chang was a Project Leader and member of the Healthcare Practice at The Boston Consulting. Dr. Chang obtained her M.D. and Ph.D. in Biophysics from Harvard University. Her work on the stochasticity of cell fate transitions was published in the journal Nature. Dr. Chang obtained clinical training in internal medicine and ophthalmology at the Beth Israel Deaconess Medical Center and Massachusetts Eye and Ear Infirmary. She is a licensed internal medicine physician in the District of Columbia and currently based in San Francisco.